Adenoid Cystic Carcinoma
📧 Sign up to get email alerts when something new happens for Adenoid Cystic Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) [Phase 2]
Phase 2 trial evaluating rivoceranib in recurrent or metastatic adenoid cystic carcinoma has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors [Phase 2]
This Phase 2 trial update describes testing nivolumab plus ipilimumab in patients with a broad set of rare tumors and notes the study status…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Becotatug Vedotin (MRG003) with Epirubicin as neoadjuvant therapy for EGFR-positive, unresectable recurr…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 trial of 177Lu-PNT2002 (177Lu-PSMA radiopharmaceutical) for PSMA-positive Adenoid Cystic Carcinoma was terminated. The update does…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Ga-68 PSMA-11 PET/CT as a diagnostic scan to detect therapy response in metastatic adenoid cystic carcin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma [Phase 2]
Phase 2 trial evaluating regorafenib in patients with progressive, recurrent, or metastatic adenoid cystic carcinoma has completed, with res…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) [Phase 1]
Poseida Therapeutics conducted a Phase 1 trial of P-PSMA-101 CAR-T cells in metastatic castration-resistant prostate cancer and advanced sal…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Surgical Strategy for Head and Neck Adenoid Cystic Cancer
Clinical trial update detailing the study of surgical strategies for adenoid cystic carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 trial evaluating axitinib in combination with avelumab for recurrent or metastatic adenoid cystic carcinoma has completed enrollme…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) [Phase 2]
Phase 2 trial evaluating rivoceranib for recurrent or metastatic adenoid cystic carcinoma has been terminated. The update does not include n…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma [Phase 2]
Phase 2 study of axitinib for recurrent or metastatic adenoid cystic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations [Phase 2]
Phase 2 clinical trial update for AL101 in patients with activating Notch mutations in Adenoid Cystic Carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies [Phase 1, Phase 2]
Early-phase study of CB-103 in adults with various advanced solid tumors and hematologic malignancies has been terminated; results were post…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating Lutetium-177-PSMA radioligand therapy for advanced salivary gland cancers has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Study of Everolimus (RAD001) in Combination With Lenalidomide [Phase 1]
Phase 1 trial evaluating everolimus in combination with lenalidomide for solid organ malignancies and adenoid cystic carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma [Phase 2]
Phase 2 trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 trial evaluating pembrolizumab with or without radiation in recurrent or metastatic adenoid cystic carcinoma has completed with re…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma [Phase 2]
Phase 2 clinical trial updating on vorinostat for locally advanced, recurrent, or metastatic adenoid cystic carcinoma with completed status …
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma [Phase 2]
Phase 2 trial evaluating particle therapy with or without apatinib for head and neck adenoid cystic carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial investigating apatinib for adenoid cystic carcinoma of the head and neck; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma [Phase 2]
Phase 2 study of dovitinib in Adenoid Cystic Carcinoma has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma [Phase 2]
This Phase 2 trial evaluating axitinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma has been completed. Resul…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety [Phase 2]
Phase 2 study of chidamide for advanced adenoid cystic carcinoma of the head and neck to assess efficacy and safety; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) [NA]
This update notes the completion of a compassionate-use trial of Brontictuzumab for Adenoid Cystic Carcinoma, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers [Phase 2]
This ClinicalTrials.gov update reports the results of a Phase 2 trial of lapatinib in patients with recurrent and/or metastatic adenoid cyst…